Überblick


David M. Santangelo represents life sciences and biopharmaceutical companies in a variety of corporate transactions and commercial undertakings with peer companies, universities and academic institutions, including licenses and collaborations, product acquisitions and dispositions, distribution arrangements, development agreements, manufacturing and supply agreements, services agreements, clinical trial agreements, sponsored research agreements, quality agreements and technology transfers. He advises industry clients at all stages of the product life cycle on their strategic alliances and all manner of commercial contracting relevant to both their daily operations and long-term planning. David serves as an outside general counsel to many early stage and smaller clients, and as a trusted advisor to more mature, middle market and large cap companies, both public and private.

Mehr anzeigen

Ausgewählte Referenzmandate


  • Represented Recro Pharma, Baudax Bio, Seagen (f/k/a Seattle Genetics), Enterin, Aro Biotherapeutics, Windtree Therapeutics, Edwards Lifesciences, Code Bio, KBP Biosciences, Personal Genome Diagnostics (PGDx), FlowMetric, Cognition Therapeutics, TELA Bio, BioXcel Therapeutics, Purdue Pharma and/or their affiliates in connection with the negotiation of various development, manufacturing, supply, distribution, services, clinical trial, quality assurance and similar arrangements*
  • Represented Ocugen, Inc. in connection with its entry into a Co-Development, Supply and Commercialization Agreement with Bharat Biotech International Limited, pursuant to which Ocugen obtained an exclusive right and license under certain of Bharat Biotech’s intellectual property rights to develop, manufacture and commercialize COVAXIN® for the prevention of COVID-19 caused by SARS-CoV-2 in humans in the United States*
  • Counsel to Ocugen, Inc. in connection with its entry into a co-development and commercialization agreement with a company headquartered in China for the co-development and worldwide commercialization of a novel gene therapy*

Mehr anzeigen

Qualifikation


Education
Northwestern University Pritzker School of Law, JD, 2001
Cornell University, BA, with distinction, 1998

Admissions
New York

David M. Santangelo

Einblicke & Events / Medien

No results using the selected filter(s)